Description: Hofseth BioCare ASA engages in providing value added biomarine ingredients for human and animal applications in Norway and internationally. Its products include Brilliant salmon oil; OmeGo salmon oil for the maintenance of healthy cholesterol and cardiovascular function; ProGo, a salmon protein hydrolysate powder used as a fast absorbing protein supplement; CalGo, a marine calcium powder produced to support cartilage function and joint health; CollaGo, a collagen peptide powder to enhance the beauty of hair, skin, and nails; and PetGo, a non-soluble protein. The company distributes its products through distributors, agents, and its own sales force. It has a research agreement with Stanford University School of Medicine for pre-clinical and clinical research on necrotizing enterocolitis and irritable bowel syndrome. The company was founded in 2000 and is headquartered in Ålesund, Norway.
Home Page: www.hofsethbiocare.no
Kipervikgata 13
Ålesund,
6003
Norway
Phone:
47 73 10 22 00
Officers
| Name | Title |
|---|---|
| Mr. Jon Olav Odegard | Chief Exec. Officer |
| Mr. Karl Inge Slotsvik | Chief Operating Officer |
| Dr. Bomi Framroze | Chief Scientific Officer |
| Mr. James Berger | Chief Commercial Officer |
| Angelika Florvaag | Chief Quality Officer |
| Dr. Crawford Currie | Head of Medical R&D and Director |
| Dr. Tanja Schaffer | EVP of Global Ingredients Division & CEO of HBC Switzerland GmbH |
| Mr. Matt Mixter | Managing Partner of Hofseth North America |
| Dr. Olav Flaten | Exec. |
Exchange: OL
Country: NO
Currency: Norwegian Krone (kr)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 5.1862 |
| Price-to-Sales TTM: | 8.2921 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 63 |